Compound 60 has an exceedingly high affinity to MDM2 (Ki < 1 nM), powerful mobile action, and an excellent oral pharmacokinetic profile. Compound sixty is capable of attaining entire and very long-lasting tumor regression in vivo and is also now in stage I scientific trials for most cancers therapy. At https://collinsj307yei1.wikicommunication.com/user